- Correction
- Open access
- Published:
Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer
BMC Medicine volume 20, Article number: 265 (2022)
The Original Article was published on 13 May 2022
Correction: BMC Med 20, 187 (2022)
https://doi.org/10.1186/s12916-022-02356-7
After publication of the original article [1], it came to the authors’ attention that there is an error in the originally-published version of Additional file 1: Table S2 and Table S3. In the univariate and multivariate regression analyses of the association between baseline plasma or tumor tissue IL-6 levels and clinical factors for the prediction of progression-free survival (PFS), the results of smoking history were lost.
The correct version of Additional file 1: Table S2 and Table S3 is published in this erratum.
Reference
Liu C, Yang L, Xu H, Zheng S, Wang Z, Wang S, et al. Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Med. 2022;20(1):187. https://doi.org/10.1186/s12916-022-02356-7.
Author information
Authors and Affiliations
Corresponding authors
Supplementary Information
Additional file 1: Table S2
. Univariate and multivariate regression analyses of the association between baseline plasma IL-6 levels and clinical factors for the prediction of PFS. Table S3. Univariate and multivariate regression analyses of the relationship between baseline tumor tissue IL-6 levels and clinical factors for the prediction of PFS.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Liu, C., Yang, L., Xu, H. et al. Correction: Systematic analysis of IL-6 as a predictive biomarker and desensitizer of immunotherapy responses in patients with non-small cell lung cancer. BMC Med 20, 265 (2022). https://doi.org/10.1186/s12916-022-02492-0
Published:
DOI: https://doi.org/10.1186/s12916-022-02492-0